Liver-directed regional therapy in the multi-disciplinary management of hepatocellular cancer

Maheswari Senthil, Brian Mailey, Lucille Leong, Vincent Chung, Yun Yen, Yi Jen Chen, Howard Marx, Joseph Kim

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is a major worldwide health concern with an increasing incidence in the United States. Orthotopic liver transplantation (OLT) has been established as the gold standard for curative therapy of HCC. Because of limited organ supply and socioeconomic factors, OLT is often not a viable option. Surgical resection and ablation are also effective for providing long-term survival. However, most patients are ineligible for curative surgical therapy due to advanced disease. For these patients, effective treatment options have been lacking. Systemic chemotherapy and even recent biologic, targeted agents have shown little to minimal efficacy. Liver-directed regional therapies, including trans-arterial chemoembolization (TACE) and selective internal radiation treatment (SIRT) with Yttrium-90 radioembolization have emerged in recent years as effective therapies to provide local control of disease. Randomized trials have demonstrated a survival benefit for TACE, and SIRT has shown efficacy as an embolic alternative to TACE. Here we review the experience of liver-directed regional therapies and provide a clear rationale for their implementation in a multi-disciplinary algorithmic approach to the management of HCC.

Original languageEnglish
Pages (from-to)19-25
Number of pages7
JournalCurrent Cancer Therapy Reviews
Volume6
Issue number1
DOIs
Publication statusPublished - Feb 2010
Externally publishedYes

Keywords

  • Chemoembolization
  • Hepatocellular cancer
  • Liver-directed therapy
  • Radioembolization
  • Regional therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Liver-directed regional therapy in the multi-disciplinary management of hepatocellular cancer'. Together they form a unique fingerprint.

  • Cite this